Clinical trial
"PTHrP(1-36) IV Dose Escalation Study"
NCT00177411 · University of Pittsburgh, Other · Withdrawn
Key facts
| NCT number | NCT00177411 |
|---|---|
| Title | "PTHrP(1-36) IV Dose Escalation Study" |
| Official title | "Determining the Maximum Tolerable Dose and Pharmacokinetic Parameters of Intravenous PTHrP(1-36)" |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Parathyroid Hormone-related Protein |
| Enrollment | 0 |
| Start date | Jul 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: